12/25/2023Oncoshot Teams Up with Zhejiang Ablaze Medicine to Drive Data-Powered ...

12/10/2023WuXi Biologics Successfully Implemented a Fully Integrated Continuous ...

11/13/2023Boehringer Ingelheim and ChromX Health Join Hands to Research Lung Dis...

11/7/2023WuXi XDC Eyes Up to $471M in Hong Kong IPO

11/1/2023Resolian Acquires China-Based Bioanalytical CRO Denali Medpharma

10/17/2023China: The New Frontier for Western CDMOs? (Contract Pharma)

9/28/2023Chime Biologics Enters Strategic Deal with Kings Pharm to Accelerate B...

9/26/2023China's Shifting Cost Dynamic to Help It Develop Own Biologics Niche: ...

9/26/2023WuXi Debuts First Vaccine CDMO Site in China

9/24/2023Chime Biologics Enter Global Strategic Deal with Panolos for Multi-spe...

9/24/2023PackGene and Kudo Partner to Offer Customized mRNA Manufacturing Servi...

8/16/2023Biocytogen Pharma Announces Opening of Waltham, MA Facility

8/15/2023Aurisco Pharma's Plant in Yangzhou Passes USFDA Inspection

7/28/2023WuXi Vaccines' First Chinese Drug Substance Facility Released for GMP ...

7/17/2023WuXi STA Debuts Its First High Potency Sterile Injectable Manufacturin...

7/10/2023WuXi Biologics Announces Proposed Spin-off and Separate Listing of WuX...

5/17/2023WuXi Bio Enters Manufacturing Partnership with InflaRx to Advance Gohi...

5/10/2023Cytoniche Biotech Opens Center of Excellence in China

4/19/2023Crystal Pharmatech's CDMO BU Receives China Drug Product Manufacturing...

4/5/2023WuXi STA Adds New Peptide Manufacturing Capacity and Large-Scale Conti...

4/5/2023Pharmaron Plans UK Gene Therapy Expansion

3/30/2023Boehringer Ingelheim Remains Confident of Its China Prospects Despite ...

1/5/2023GSK and WuXi Biologics Enter License Deal on Multiple Novel Bi- & Mult...

1/5/2023Aurisco to Build Oligonucleotides Manufacturing Facility in China

12/2/2022China's Challenge in the Drug Services Field (C&EN)

11/30/2022WuXi STA Launches Another Parenteral Formulation Manufacturing Line at...

11/23/2022WuXi AppTec Begins Construction of Wuxi STA's East China R&D Facility

11/8/2022HEC Barred from Selling Linagliptin Products following Patent Ruling (...

10/26/2022WuXi Bio Launches 48,000L Commercial Drug Substance Manufacturing Faci...

10/20/2022IQVIA Forecasts Chinese CMDO Market to Grow 20% CAGR Before 2025

Page:2/18 Total number of articles:522: [First][<<] [1] [2] [3] [4] [5] [>>] [End]